Subbu Nambi
Stock Analyst at Guggenheim
(2.20)
# 2,730
Out of 4,944 analysts
42
Total ratings
44.12%
Success rate
-1.97%
Average return
Main Sectors:
Stocks Rated by Subbu Nambi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DHR Danaher | Reiterates: Buy | $250 | $207.55 | +20.45% | 2 | Jul 23, 2025 | |
| CAI Caris Life Sciences | Initiates: Buy | $32 | $35.88 | -10.81% | 1 | Jul 14, 2025 | |
| WGS GeneDx Holdings | Maintains: Buy | $88 → $115 | $118.50 | -2.95% | 1 | Jun 30, 2025 | |
| TEM Tempus AI | Maintains: Buy | $65 → $75 | $70.03 | +7.10% | 3 | Jun 30, 2025 | |
| NEOG Neogen | Maintains: Buy | $13 → $10 | $5.20 | +92.31% | 3 | Jun 30, 2025 | |
| ILMN Illumina | Maintains: Buy | $122 → $114 | $99.01 | +15.15% | 3 | May 9, 2025 | |
| TWST Twist Bioscience | Reiterates: Buy | $50 | $28.12 | +77.81% | 2 | May 6, 2025 | |
| CYRX Cryoport | Reiterates: Buy | $10 | $8.73 | +14.55% | 1 | Apr 16, 2025 | |
| EXAS Exact Sciences | Reiterates: Buy | $60 | $42.52 | +41.11% | 2 | Apr 11, 2025 | |
| MYGN Myriad Genetics | Downgrades: Neutral | n/a | $6.12 | - | 2 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $37 | $29.10 | +27.15% | 3 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $32.66 | - | 3 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $56 | $56.18 | -0.32% | 5 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $170 → $200 | $159.81 | +25.15% | 2 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $35.47 | - | 1 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $3.08 | +94.81% | 1 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $6 | $0.71 | +741.63% | 1 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $13.32 | - | 3 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $121.50 | - | 1 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $19.33 | +29.33% | 1 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $1.28 | - | 1 | Dec 14, 2023 |
Danaher
Jul 23, 2025
Reiterates: Buy
Price Target: $250
Current: $207.55
Upside: +20.45%
Caris Life Sciences
Jul 14, 2025
Initiates: Buy
Price Target: $32
Current: $35.88
Upside: -10.81%
GeneDx Holdings
Jun 30, 2025
Maintains: Buy
Price Target: $88 → $115
Current: $118.50
Upside: -2.95%
Tempus AI
Jun 30, 2025
Maintains: Buy
Price Target: $65 → $75
Current: $70.03
Upside: +7.10%
Neogen
Jun 30, 2025
Maintains: Buy
Price Target: $13 → $10
Current: $5.20
Upside: +92.31%
Illumina
May 9, 2025
Maintains: Buy
Price Target: $122 → $114
Current: $99.01
Upside: +15.15%
Twist Bioscience
May 6, 2025
Reiterates: Buy
Price Target: $50
Current: $28.12
Upside: +77.81%
Cryoport
Apr 16, 2025
Reiterates: Buy
Price Target: $10
Current: $8.73
Upside: +14.55%
Exact Sciences
Apr 11, 2025
Reiterates: Buy
Price Target: $60
Current: $42.52
Upside: +41.11%
Myriad Genetics
Apr 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $6.12
Upside: -
Apr 9, 2025
Maintains: Buy
Price Target: $45 → $37
Current: $29.10
Upside: +27.15%
Feb 24, 2025
Reiterates: Buy
Price Target: n/a
Current: $32.66
Upside: -
Feb 24, 2025
Reiterates: Buy
Price Target: $56
Current: $56.18
Upside: -0.32%
Jan 17, 2025
Maintains: Buy
Price Target: $170 → $200
Current: $159.81
Upside: +25.15%
Oct 17, 2024
Initiates: Neutral
Price Target: n/a
Current: $35.47
Upside: -
Jun 27, 2024
Initiates: Buy
Price Target: $6
Current: $3.08
Upside: +94.81%
Jun 27, 2024
Initiates: Buy
Price Target: $6
Current: $0.71
Upside: +741.63%
Jun 26, 2024
Downgrades: Neutral
Price Target: n/a
Current: $13.32
Upside: -
Jun 18, 2024
Initiates: Neutral
Price Target: n/a
Current: $121.50
Upside: -
Dec 14, 2023
Initiates: Buy
Price Target: $25
Current: $19.33
Upside: +29.33%
Dec 14, 2023
Initiates: Neutral
Price Target: n/a
Current: $1.28
Upside: -